Patently innovative: how pharmaceutical firms use emerging patent law to extend monopolies on blockbuster drugs
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Oxford
Biohealthcare
2012
|
Schlagworte: | |
Online-Zugang: | DE-1046 Volltext |
Beschreibung: | Includes bibliographical references and index Patently innovative provides a review of the importance of traditional patent law and emerging linkage regulations for pharmaceutical products on the global stage, with a focus on the linkage regime in Canada. The primary focus is on how innovation in the pharmaceutical sector can be strongly regulated and how government regulation can either stimulate or inhibit development of breakthrough products. Includes empirical research to relate innovation to drug lawA multidisciplinary approach is taken, including the intersection of IP (intellectual property) law, drug law and innovationDiscusses the impact of government regulation on firm innovation |
Beschreibung: | xx, 275 pages |
ISBN: | 1908818085 9781908818089 9781907568121 1907568123 |
Internformat
MARC
LEADER | 00000nam a2200000zc 4500 | ||
---|---|---|---|
001 | BV044388384 | ||
003 | DE-604 | ||
007 | cr|uuu---uuuuu | ||
008 | 170630s2012 xx o|||| 00||| eng d | ||
020 | |a 1908818085 |9 1-908818-08-5 | ||
020 | |a 9781908818089 |9 978-1-908818-08-9 | ||
020 | |a 9781907568121 |9 978-1-907568-12-1 | ||
020 | |a 1907568123 |9 1-907568-12-3 | ||
035 | |a (ZDB-33-ESD)ocn823041381 | ||
035 | |a (OCoLC)823041381 | ||
035 | |a (DE-599)BVBBV044388384 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
082 | 0 | |a 343.0786151 |2 22 | |
100 | 1 | |a Bouchard, Ron A. |e Verfasser |4 aut | |
245 | 1 | 0 | |a Patently innovative |b how pharmaceutical firms use emerging patent law to extend monopolies on blockbuster drugs |c Ron A. Bouchard |
264 | 1 | |a Oxford |b Biohealthcare |c 2012 | |
300 | |a xx, 275 pages | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
500 | |a Includes bibliographical references and index | ||
500 | |a Patently innovative provides a review of the importance of traditional patent law and emerging linkage regulations for pharmaceutical products on the global stage, with a focus on the linkage regime in Canada. The primary focus is on how innovation in the pharmaceutical sector can be strongly regulated and how government regulation can either stimulate or inhibit development of breakthrough products. Includes empirical research to relate innovation to drug lawA multidisciplinary approach is taken, including the intersection of IP (intellectual property) law, drug law and innovationDiscusses the impact of government regulation on firm innovation | ||
650 | 7 | |a LAW / Military |2 bisacsh | |
650 | 7 | |a Drug development |2 fast | |
650 | 7 | |a Drugs |2 fast | |
650 | 7 | |a Patent extensions |2 fast | |
650 | 4 | |a Drugs |v Patents | |
650 | 4 | |a Patent extensions | |
650 | 4 | |a Drug development | |
856 | 4 | 0 | |u http://www.sciencedirect.com/science/book/9781907568121 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-33-ESD | ||
912 | |a ZDB-33-EBS | ||
943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-029790605 | |
966 | e | |u http://www.sciencedirect.com/science/book/9781907568121 |l DE-1046 |p ZDB-33-ESD |q FAW_PDA_ESD |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1816805427567919104 |
---|---|
adam_text | |
any_adam_object | |
author | Bouchard, Ron A. |
author_facet | Bouchard, Ron A. |
author_role | aut |
author_sort | Bouchard, Ron A. |
author_variant | r a b ra rab |
building | Verbundindex |
bvnumber | BV044388384 |
collection | ZDB-33-ESD ZDB-33-EBS |
ctrlnum | (ZDB-33-ESD)ocn823041381 (OCoLC)823041381 (DE-599)BVBBV044388384 |
dewey-full | 343.0786151 |
dewey-hundreds | 300 - Social sciences |
dewey-ones | 343 - Military, tax, trade & industrial law |
dewey-raw | 343.0786151 |
dewey-search | 343.0786151 |
dewey-sort | 3343.0786151 |
dewey-tens | 340 - Law |
discipline | Rechtswissenschaft |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000zc 4500</leader><controlfield tag="001">BV044388384</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170630s2012 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1908818085</subfield><subfield code="9">1-908818-08-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781908818089</subfield><subfield code="9">978-1-908818-08-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781907568121</subfield><subfield code="9">978-1-907568-12-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1907568123</subfield><subfield code="9">1-907568-12-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-33-ESD)ocn823041381</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)823041381</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044388384</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">343.0786151</subfield><subfield code="2">22</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bouchard, Ron A.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Patently innovative</subfield><subfield code="b">how pharmaceutical firms use emerging patent law to extend monopolies on blockbuster drugs</subfield><subfield code="c">Ron A. Bouchard</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford</subfield><subfield code="b">Biohealthcare</subfield><subfield code="c">2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xx, 275 pages</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Patently innovative provides a review of the importance of traditional patent law and emerging linkage regulations for pharmaceutical products on the global stage, with a focus on the linkage regime in Canada. The primary focus is on how innovation in the pharmaceutical sector can be strongly regulated and how government regulation can either stimulate or inhibit development of breakthrough products. Includes empirical research to relate innovation to drug lawA multidisciplinary approach is taken, including the intersection of IP (intellectual property) law, drug law and innovationDiscusses the impact of government regulation on firm innovation</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LAW / Military</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug development</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Patent extensions</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="v">Patents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Patent extensions</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug development</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/book/9781907568121</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-33-ESD</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-33-EBS</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029790605</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://www.sciencedirect.com/science/book/9781907568121</subfield><subfield code="l">DE-1046</subfield><subfield code="p">ZDB-33-ESD</subfield><subfield code="q">FAW_PDA_ESD</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV044388384 |
illustrated | Not Illustrated |
indexdate | 2024-11-26T17:04:34Z |
institution | BVB |
isbn | 1908818085 9781908818089 9781907568121 1907568123 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029790605 |
oclc_num | 823041381 |
open_access_boolean | |
owner | DE-1046 |
owner_facet | DE-1046 |
physical | xx, 275 pages |
psigel | ZDB-33-ESD ZDB-33-EBS ZDB-33-ESD FAW_PDA_ESD |
publishDate | 2012 |
publishDateSearch | 2012 |
publishDateSort | 2012 |
publisher | Biohealthcare |
record_format | marc |
spelling | Bouchard, Ron A. Verfasser aut Patently innovative how pharmaceutical firms use emerging patent law to extend monopolies on blockbuster drugs Ron A. Bouchard Oxford Biohealthcare 2012 xx, 275 pages txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references and index Patently innovative provides a review of the importance of traditional patent law and emerging linkage regulations for pharmaceutical products on the global stage, with a focus on the linkage regime in Canada. The primary focus is on how innovation in the pharmaceutical sector can be strongly regulated and how government regulation can either stimulate or inhibit development of breakthrough products. Includes empirical research to relate innovation to drug lawA multidisciplinary approach is taken, including the intersection of IP (intellectual property) law, drug law and innovationDiscusses the impact of government regulation on firm innovation LAW / Military bisacsh Drug development fast Drugs fast Patent extensions fast Drugs Patents Patent extensions Drug development http://www.sciencedirect.com/science/book/9781907568121 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Bouchard, Ron A. Patently innovative how pharmaceutical firms use emerging patent law to extend monopolies on blockbuster drugs LAW / Military bisacsh Drug development fast Drugs fast Patent extensions fast Drugs Patents Patent extensions Drug development |
title | Patently innovative how pharmaceutical firms use emerging patent law to extend monopolies on blockbuster drugs |
title_auth | Patently innovative how pharmaceutical firms use emerging patent law to extend monopolies on blockbuster drugs |
title_exact_search | Patently innovative how pharmaceutical firms use emerging patent law to extend monopolies on blockbuster drugs |
title_full | Patently innovative how pharmaceutical firms use emerging patent law to extend monopolies on blockbuster drugs Ron A. Bouchard |
title_fullStr | Patently innovative how pharmaceutical firms use emerging patent law to extend monopolies on blockbuster drugs Ron A. Bouchard |
title_full_unstemmed | Patently innovative how pharmaceutical firms use emerging patent law to extend monopolies on blockbuster drugs Ron A. Bouchard |
title_short | Patently innovative |
title_sort | patently innovative how pharmaceutical firms use emerging patent law to extend monopolies on blockbuster drugs |
title_sub | how pharmaceutical firms use emerging patent law to extend monopolies on blockbuster drugs |
topic | LAW / Military bisacsh Drug development fast Drugs fast Patent extensions fast Drugs Patents Patent extensions Drug development |
topic_facet | LAW / Military Drug development Drugs Patent extensions Drugs Patents |
url | http://www.sciencedirect.com/science/book/9781907568121 |
work_keys_str_mv | AT bouchardrona patentlyinnovativehowpharmaceuticalfirmsuseemergingpatentlawtoextendmonopoliesonblockbusterdrugs |